Browsing: cardiovascular

In a momentous occasion, the Western Visayas Medical Center (WVMC) unveiled its Heart and Lung building, marking a significant leap forward in the region’s healthcare landscape. Nestled in the heart of Western Visayas, this state-of-the-art facility stands as a beacon of excellence, offering comprehensive cardiovascular and pulmonary care services to patients across the region.

Intermittent Fasting has been gaining in popularity. A recent study found that 10% of the American population participates in this diet. It is a caloric restriction revolving around a short window for eating and a comparatively larger window for fasting. In this article, we review the health benefits against the potential cardiovascular concerns.

Log In or Register as a healthcare professional to read the full article.

Southeast Asian countries like Thailand, Vietnam, Malaysia, and the Philippines have been experiencing record-breaking heat. These recent extreme temperatures have led to heat stress-related consequences like agricultural disruptions and power outages. In South Vietnam, whole rice fields dried up. Additionally, schools were suspended in the Philippines after temperatures rose above 42 degrees Celsius. Meanwhile, across Thailand, temperatures soared and broke records continuously for 13 months!

Log In or Register as a healthcare professional to read the full article.

In response to alarming statistics indicating that six out of 10 Filipinos pass away without receiving medical attention, a proactive legislative initiative has emerged. Bicol Saro Party-list Representative Brian Raymund Yamsuan has taken a bold step by introducing House Bill (HB) No.1785, dubbed the proposed Free Annual Medical Check-up Act.

In a momentous stride forward for cardiac healthcare, St. Luke’s Medical Center proudly celebrates the grand opening of its highly anticipated Center for Structural Heart and Vascular Interventions (CSHVI). This cutting-edge facility stands as a towering symbol of innovation, poised to redefine the very landscape of cardiovascular care. With its pioneering approach to minimally invasive treatment options, the CSHVI is set to revolutionise how patients grappling with complex heart and vascular diseases are cared for.

As the world shifts its focus from the immediate threat of the COVID-19 pandemic, another health concern, often silent but equally impactful, is gaining prominence. Non-alcoholic Fatty Liver Disease (NAFLD), recognised as the “silent epidemic,” has emerged as a significant global health issue, affecting an estimated 38% of the world’s population.

With the emergence and increasing popularity of glucagon-like peptide 1 (GLP-1) agonists for the treatment of obesity in recent years, it might be worth investigating if these agents are able to reduce the cardiovascular risks associated with overweight and obesity, especially since they have been shown to reduce risk of major adverse cardiovascular events in patients with type 2 diabetes who are at high cardiovascular risk.

Log In or Register as a healthcare professional to read the full article.